Molecular mechanisms orchestrating intratumoral heterogeneity in Kras-driven carcinomas

被引:0
|
作者
Azimi, Roxana
机构
关键词
D O I
10.1158/1538-7445.AM2016-2403
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2403
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Opening a New GATAway for Treating KRAS-Driven Lung Tumors
    Barbacid, Mariano
    CANCER CELL, 2012, 21 (05) : 598 - 600
  • [42] SPARK, studying pathways of resistance in KRAS-driven cancers: A remote plasma ctDNA participation study to identify mechanisms of resistance to KRAS inhibitors
    Ricciuti, Biagio
    Lee, Elinton
    Conneran, Terri
    King, Jennifer C.
    Harper, Allison
    Lamberti, Giuseppe
    Brisbane, Gifty
    Hoskova, Katerina
    Clifford, Sarah
    Murphy, Jo-Ellen
    Huang, Richard S. P.
    Oxnard, Geoffrey R.
    Addario, Anthony
    Erwin, Richard M.
    Tolba, Khaled
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] The Effects of Ezh2 Mutation on Kras-Driven Adenocarcinoma
    Mandias, Hannah
    Mao, Suifang
    Xue, Bin
    Fuziwara, Cesar
    He, Lin
    FASEB JOURNAL, 2020, 34
  • [44] Addicted to proteostasis: How KRAS-driven cancers acquire resistance to clinical KRAS inhibitors
    Klein, Austin T.
    Mendillo, Marc L.
    CELL CHEMICAL BIOLOGY, 2023, 30 (11) : 1334 - 1336
  • [45] Arf suppresses the growth and progression of Kras-driven lung tumors
    Busch, Stephanie E.
    Gurley, Kay E.
    Moser, Russell D.
    Kelly-Spratt, Karen S.
    Kemp, Christopher J.
    CANCER RESEARCH, 2011, 71
  • [46] CRAF dimerization with ARAF regulates KRAS-driven tumor growth
    Venkatanarayan, Avinashnarayan
    Liang, Jason
    Yen, Ivana
    Shanahan, Frances
    Haley, Benjamin
    Phu, Lilian
    Verschueren, Erik
    Hinkle, Trent B.
    Kan, David
    Segal, Ehud
    Long, Jason E.
    Lima, Tony
    Liau, Nicholas P. D.
    Sudhamsu, Jawahar
    Li, Jason
    Klijn, Christiaan
    Piskol, Robert
    Junttila, Melissa R.
    Shaw, Andrey S.
    Merchant, Mark
    Chang, Matthew T.
    Kirkpatrick, Donald S.
    Malek, Shiva
    CELL REPORTS, 2022, 38 (06):
  • [47] Targeting copper metabolism to defeat KRAS-driven colorectal cancer
    Aubert, Leo
    Nandagopal, Neethi
    Roux, Philippe P.
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (06)
  • [48] Identification and characterization of factors required for KRAS-driven pancreatic tumorigenesis
    Lewis, Brian C.
    CANCER RESEARCH, 2015, 75
  • [49] Immunogenic chemotherapy effectively inhibits KRAS-Driven lung cancer
    Wang, Dong
    Cong, Jingjing
    Fu, Binqing
    Zheng, Xiaohu
    Sun, Rui
    Tian, Zhigang
    Wei, Haiming
    CANCER LETTERS, 2020, 492 : 31 - 43
  • [50] Rare codons capacitate Kras-driven de novo tumorigenesis
    Pershing, Nicole L. K.
    Lampson, Benjamin L.
    Counter, Christopher M.
    CANCER RESEARCH, 2017, 77